Qrativ Company
Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
Technology:
Cancer
Industry:
Artificial Intelligence, Biotechnology, Data Processing, Drug Repurposing, Machine Learning, Pharmaceutical
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
3
Total Funding:
8300000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-07-14
Last Funding Type:
Series A
Register and Claim Ownership